NCT03215316View on ClinicalTrials.gov

Screening Expiratory Flow Limitation by Flow-time Curve

CompletedOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions

ARDS, Human

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors

lead

Unity Health Toronto

OTHER

NCT03215316 - Screening Expiratory Flow Limitation by Flow-time Curve | Biotech Hunter | Biotech Hunter